Dan Bongino reveals FBI’s plans to investigate cocaine found in the White House during Biden admin and other past cases

by Dillon Burroughs

Photo: Alamy

The FBI is launching renewed investigations into three high-profile incidents involving alleged public corruption, including the unsolved 2021 D.C. pipe bomb case, the discovery of cocaine at the White House during the Biden administration and the 2022 leak of the Supreme Court’s Dobbs v. Jackson draft opinion, according to Deputy Director Dan Bongino.

Bongino announced the developments on Monday in a post to X, stating that he and FBI Director Kash Patel had decided to reinvestigate the issues.

“Shortly after swearing in, the Director and I evaluated a number of cases of potential public corruption that, understandably, have garnered public interest. We made the decision to either re-open, or push additional resources and investigative attention, to these cases,” Bongino wrote.

“These cases are the DC pipe bombing investigation, the cocaine discovery at the prior administration’s White House, and the leak of the Supreme Court Dobbs case. I receive requested briefings on these cases weekly and we are making progress. If you have any investigative tips on these matters that may assist us then please contact the FBI,” he continued.

He also addressed why he and Patel have avoided most public interviews since joining the bureau.

“We decided early on to limit our media footprint overall in order to keep the attention on the work being done,” he said. “There are both positives and negatives to this approach. We have chosen to communicate, in writing, on this platform to fill some of the inevitable information vacuums.”

Bongino noted that due to his work in a SCIF (Sensitive Compartmented Information Facility), phone access is limited, which affects how frequently he can review public feedback. He added that more updates would be shared to clarify outstanding questions from a recent interview he and Patel conducted.

The cocaine case Bongino mentioned involved the discovery of the drug inside a work area in the West Wing of the White House on July 2, 2023, near a public entrance where visitors typically store their belongings. The Secret Service closed its investigation after it claimed that it found no usable DNA or fingerprints and no conclusive evidence on security footage.

You may also like